DYNAMIC CONTRAST ENHANCED 1H-MAGNETIC RESONANCE IMAGING IN ASSESSMENT OF SKELETAL MUSCLE AND FIBROSARCOMA PERFUSION

A. M. Babsky, N. Bansal


DOI: http://dx.doi.org/10.30970/sbi.1403.625

Abstract


Background. The detection of neoplastic transformation and prediction of the thera­peutic response are very important for effective cancer therapy. Current assessment of tumor treatment efficacy relies on evaluating changes in the tumor size or volume, weeks to months after the assumption of a therapeutic protocol. The tissue perfusion is one of the most important parameter to estimate the neoplastic progress and the efficacy of antitumor therapy. 1H-magnetic resonance imaging (MRI) is an effective tool that provides distinctive information related to structural, cellular, apoptotic, and necrotic changes in tumor tissue. The technique can be used widely for tumor detection and monitoring of the response to treatment.
Methods. Dynamic contrast enhanced 1H-MRI was used for the assessment of tumor perfusion parameters in normal muscle and in subcutaneous Radiation Infused Fibrosarcoma – 1 (RIF-1) developed under the skin in C3H mice. Gadolinium (20 mM) was used as a capillaries perfusion tracer. Therapy of RIF-1 was administered by a single intraperitoneal injection of 5-fluorouracil (150 mg/kg). MRI experiments were performed before and 3 days after the treatment.
Results. Dynamic contrast enhanced 1H-MRI has shown a much lower perfusion rate in RIF-1 tumor compared to skeletal muscle. 5-fluorouracil caused a significant decrease in subcutaneous RIF-1 volume on days 2 and 3 post-treatment, as well as an increase in tumor inflow measured by Dynamic contrast enhanced 1H-MRI. An increase in tumor tissue perfusion correlated with an increase in tissue apparent diffusion coefficient and total Na+ concentration following 5-fluorouracil chemotherapy reflect an increase in extracellular space and vasodilatation. On the other hand, as it was shown in our previous publications, the lower intracellular Na+ concentration and glucose uptake in treated by 5-fluorouracil tumors compared with control tumors suggest a shift in tumor metabolism from glycolysis to oxidation and/or a decrease in cell density.
Conclusions. Method of dynamic contrast enhanced 1H-MRI in combination with other NMR methods, positron emission tomography, histology, etc. should prove useful in assessment of neoplastic transformation of tumor capillaries and efficacy of chemotherapy.


Keywords


muscle, perfusion, Gadolinium, fibrosarcoma, 5-fluorouracil, 1H-MRI

Full Text:

PDF

References


1. Airley R. Cancer Chemotherapy: Basic Science to the Clinic. Chichester: Wiley-Blackwell, 2009. 342 p.
Google Scholar

2. Babsky A.M. Functional State of Cells and Level of Na+ Under Hypoxia and Cancerogene­sis. Lviv: Ivan Franko LNU Publications, 2018. 180 p. (In Ukrainan)

3. Babsky A., Hekmatyar S.K., Zhang H., Solomon J.S., Bansal N. Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors. Neoplasia, 2005; 7: 658-666.
Crossref • PubMed • Google Scholar

4. Babsky A. M., Zhang H., Hekmatyar S. K., Hutchins G.D., Bansal N. Monitoring chemotherapeutic response in RIF-1 tumors by single-quantum and triple-quantum-filtered 23Na MRI, 1H diffusion-weighted MRI and PET imaging. Magnetic Resonance Imaging, 2007; 25(7): 1015-1023.
Crossref • PubMed • Google Scholar

5. Babsky A., George B., Bansal N. Assessment of hepatic perfusion and diffusion in CCl4 treated rat liver using magnetic resonance imaging. Visnyk Lviv University. Series Biology, 2013; 61: 3-10.
Google Scholar

6. Bhujwalla Z.M., McCoy C.L., Glickson J.D., Gillies R.J., Stubbs M. Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer, 1998; 78(5): 606-611.
Crossref • PubMed • Google Scholar

7. Bhujwalla Z. M., Artemov D., Glockner J. Tumor angiogenesis, vascularization, and contras­­tenhanced magnetic resonance imaging. Topics in Magnetic Resonance Imaging, 1999; 10(2): 92-103.
Crossref • PubMed • Google Scholar

8. Braunschweiger P.G. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res, 1988; 48(15): 4206-4210.
Google Scholar

9. Kanematsu M., Goshima S., Watanabe H., Kondo H., Kawada H., Noda Y. Moriyama N. Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. Magnetic Resonance in Medical Sciences, 2012; 11: 151-161.
Crossref • PubMed • Google Scholar

10. Lemaire L., Howe F.A., Rodrigues L.M., Griffiths J.R. Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA, 1999; 8(1): 20-26.
Crossref • PubMed • Google Scholar

11. Li S.-J., Wehrle J. P., Glickson G., Kumar N., Braunschweiger P.G. Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magnetic Resonance in Medi­cine, 1991; 22(1): 47-56.
Crossref • PubMed • Google Scholar

12. Liu Y., Wang S., Zhao X., Feng Y., Bormans G., Swinnen J., Oyen R., Huang G., Ni Y., Li Y. Predicting clinical efficacy of vascular disrupting agents in rodent models of primary and secon­dary liver cancers: an overview with imaging-histopathology correlation. Diagnostics (Basel), 2020; 10(2). pii: E78.
Crossref • PubMed • Google Scholar

13. Materne R., Smith A. M., Peeters F., Dehoux J.P., Keyeux A., Horsmans Y., Van Beers B.E. Assessment of hepatic perfusion parameters with dynamic MRI. Magnetic Resonance in Medicine, 2002; 47: 135-142.
Crossref • PubMed • Google Scholar

14. McSheehy P.M., Leach M.O., Judson I.R., Griffiths J.R. Metabolites of 2′-fluoro-2′-deoxy-D-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil. Cancer Res, 2000; 60(8): 2122-2127.
Google Scholar

15. Nishida N., Yano H., Nishida T., Kamura T., Kojiro M. Angiogenesis in cancer. Vascular. Health Risk Manag., 2006; 2(3): 213-219.
Crossref • PubMed • Google Scholar

16. Park H.S., Han J.K., Lee J.M., Kim Y.I., Woo S., Yoon J.H., Choi J.Y., Choi B.I. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model. Korean J Radiol, 2015; 16(5): 1029-1037.
Crossref • PubMed • Google Scholar

17. Poptani H., Bansal N., Graham R.A., Mancuso A., Nelson D.S., Glickson J.D. Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging. NMR Biomed., 2003; 16(2): 102-111.
Crossref • PubMed • Google Scholar

18. Poptani H., Bansal N., Jenkins W.T., Blessington D., Mancuso A., Nelson D.S., Feldman M., Delikatny E.J., Chance B., Glickson J.D. Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning. Cancer Res, 2003; 63(24): 8813-8820.
Google Scholar

19. Sijens P.E., Baldwin N.J., Ng T.C. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Magnetic Resonance in Medicine, 1991; 19(2): 373-385.
Crossref • PubMed • Google Scholar

20. Sun X., Wang H., Chen F., De Keyzer F., Yu J., Jiange Y., Feng Y., Li J., Marchal G., Ni Y. Diffusion-weighted MRI of hepatic tumor in rats: Comparison between in vivo and postmortem imaging acquisitions. Journal of Magnetic Resonance Imaging, 2009; 29: 621-628.
Crossref • PubMed • Google Scholar

21. Sun Y., Hua R. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections. Drug Des Devel Ther, 2019; 13: 1323-1334.
Crossref • PubMed • Google Scholar

22. Taouli B. (ed.). Extra-Cranial Applications of Diffusion-Weighted MRI. Cambridge, UK: University Press, 2011. 215 p.
Google Scholar

23. Thoeny H. C., De Keyzer F., Chen F., Landuyt W., Verbeken E.K., Bosmans H., Hermans R., van Oosterom A., Marchal G., Landuyt W. Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia, 2005; 7: 779-787.
Crossref • PubMed • Google Scholar

24. Yankeelov T. E., Arlinghaus L. R., Li X., Gore J.C. The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. Semin Oncol, 2011; 38(1): 16-25.
Crossref • PubMed • Google Scholar


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Studia Biologica

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.